Wnt Signaling in Renal Cell Carcinoma

被引：80
作者：
Xu, Qi [1 ]
Krause, Mirja [1 ]
Samoylenko, Anatoly [1 ]
Vainio, Seppo [1 ]
机构：
[1] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Fac Biochem & Mol Med, POB 5000, FI-90014 Oulu, Finland
来源：
CANCERS | 2016年 / 8卷 / 06期
基金：
芬兰科学院;
关键词：
renal cell carcinoma; Wnt signaling pathway; therapeutic target; development; ANTICANCER DRUG TARGETS; BETA-CATENIN; KIDNEY DEVELOPMENT; TUMOR-SUPPRESSOR; ANTAGONIST GENE; STEM-CELL; EXPRESSION; CANCER; PATHWAY; GROWTH;
D O I：
10.3390/cancers8060057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Renal cell carcinoma (RCC) accounts for 90% of all kidney cancers. Due to poor diagnosis, high resistance to the systemic therapies and the fact that most RCC cases occur sporadically, current research switched its focus on studying the molecular mechanisms underlying RCC. The aim is the discovery of new effective and less toxic anti-cancer drugs and novel diagnostic markers. Besides the PI3K/Akt/mTOR, HGF/Met and VHL/hypoxia cellular signaling pathways, the involvement of the Wnt/beta-catenin pathway in RCC is commonly studied. Wnt signaling and its targeted genes are known to actively participate in different biological processes during embryonic development and renal cancer. Recently, studies have shown that targeting this pathway by alternating/inhibiting its intracellular signal transduction can reduce cancer cells viability and inhibit their growth. The targets and drugs identified show promising potential to serve as novel RCC therapeutics and prognostic markers. This review aims to summarize the current status quo regarding recent research on RCC focusing on the involvement of the Wnt/beta-catenin pathway and how its understanding could facilitate the identification of potential therapeutic targets, new drugs and diagnostic biomarkers.
引用
收藏
页数：14
相关论文
共 50 条
[41]   Wnt3a suppresses Wnt/β-catenin signaling and cancer cell proliferation following serum deprivation [J].
He, Qingqing ;
Yan, Hongwei ;
Wo, Da ;
Liu, Junjun ;
Liu, Peng ;
Zhang, Jiankang ;
Li, Limei ;
Zhou, Bin ;
Ge, Jin ;
Li, Huashun ;
Liu, Shangfeng ;
Zhu, Weidong .
EXPERIMENTAL CELL RESEARCH, 2016, 341 (01) :32-41
[42]   Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma [J].
Huang, Jian-lin ;
Liao, Yong ;
Qiu, Ming-xing ;
Li, Jun ;
An, Yu .
TUMOR BIOLOGY, 2017, 39 (07) :1-9
[43]   MicroRNA Signature in Renal Cell Carcinoma [J].
Ghafouri-Fard, Soudeh ;
Shirvani-Farsani, Zeinab ;
Branicki, Wojciech ;
Taheri, Mohammad .
FRONTIERS IN ONCOLOGY, 2020, 10
[44]   Clinical significance of changes of expression of the Wnt/β-catenin signaling pathway in renal clear cell carcinoma [J].
Liu, Z. ;
Liu, X. -W. ;
Liu, S. -A. ;
Lv, J. -J. ;
Fu, Q. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (23) :4840-4845
[45]   Mitotic Wnt Signaling Promotes Protein Stabilization and Regulates Cell Size [J].
Acebron, Sergio P. ;
Karaulanov, Emil ;
Berger, Birgit S. ;
Huang, Ya-Lin ;
Niehrs, Christof .
MOLECULAR CELL, 2014, 54 (04) :663-674
[46]   Wnt Signaling as a Possible Promoting Factor of Cell Differentiation in Pleomorphic Adenomas [J].
Okuda, Yukiko ;
Nakano, Keisuke ;
Suzuki, Koji ;
Sugita, Yoshihiko ;
Kubo, Katsutoshi ;
Maeda, Hatsuhiko ;
Okafuji, Norimasa ;
Hasegawa, Hiromasa ;
Kawakami, Toshiyuki .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (09) :971-978
[47]   Targeting the Wnt/Beta-Catenin Pathway in Renal Cell Carcinoma [J].
Von Schulz-Hausmann, Sarah Annette ;
Schmeel, Leonard Christopher ;
Schmeel, Frederic Carsten ;
Schmidt-Wolf, Ingo G. H. .
ANTICANCER RESEARCH, 2014, 34 (08) :4101-4108
[48]   Wnt8B, transcriptionally regulated by ZNF191, promotes cell proliferation of hepatocellular carcinoma via Wnt signaling [J].
Liu, Yufeng ;
Wu, Di ;
Cheng, Hanghang ;
Chen, Lei ;
Zhang, Weidi ;
Zou, Liping ;
Gao, Qiongmei ;
Zhao, Zhonghua ;
Chen, Qi ;
Zeng, Wenjiao ;
Zhang, Zhigang ;
Jiang, Wei ;
Huang, Cheng ;
Liu, Guoyuan .
CANCER SCIENCE, 2021, 112 (02) :629-640
[49]   Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma [J].
Zhang, Xiaomei ;
Yang, Yunsheng ;
Liu, Xuefeng ;
Herman, James G. ;
Brock, Malcolm V. ;
Licchesi, Julien D. F. ;
Yue, Wen ;
Pei, Xuetao ;
Guo, Mingzhou .
EPIGENETICS, 2013, 8 (04) :373-382
[50]   IL-37 mediates the antitumor activity in renal cell carcinoma [J].
Jiang, Yazhuo ;
Wang, Yili ;
Liang, Liang ;
Gao, Yang ;
Chen, Juan ;
Sun, Yi ;
Cheng, Yongyi ;
Xu, Yonggang .
MEDICAL ONCOLOGY, 2015, 32 (11)
12345